IP Library Patent Application 12765973
Patent Application
App. No. 12/765,973

CURABLE COMPOSITIONS CONTAINING ISOCYANATE-BASED TOUGHENERS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/765,973
Abstract

The present invention relates to curable compositions comprising (a) N-arylated benzoxazines, and (b) a prepolymer produced from a diisocyanate having two isocyanate groups with different reactivity. The compositions are particularly suitable in the production of adhesives and sealants, prepregs and towpreg.

Claims (30)

1 . A curable composition comprising:

A) an N-arylated benzoxazine component, and

B) a prepolymer of the following general structure:

P—(X—CO—NH-D-NH—CO—Y-E) z

wherein

P is a z-valent residue of an oligomer or polymer,

X and Y independently are selected from the group consisting of NR′, O and S,

wherein R′ is hydrogen or a residue selected from the group consisting of aliphatic, heteroaliphatic, araliphatic, heteroaraliphatic, aromatic and heteroaromatic residues,

D is a divalent residue of a diisocyanate comprising two isocyanate groups having different reactivity, from which the two isocyanate groups with different reactivity have been removed to form two binding sites (valences),

E is a end-capping residue, selected from the group consisting of aliphatic, heteroaliphatic, araliphatic, heteroaraliphatic, aromatic and heteroaromatic residues, and

z is an integer of 1 to 12.

2 . The curable composition according to claim 1 , wherein P is selected from the group consisting of polyether residues and polyester residues.

3 . The curable composition according to claim 1 , wherein X and Y independently are NH and/or O.

4 . The curable composition according to claim 1 , wherein D is a residue obtained by removing the two isocyanate groups of a diisocyanate selected from the group consisting of 2,4-toluene diisocyanate (2,4-TDI), naphthalene 1,8-diisocyanate (1,8-NDI), 2,4′-methylenediphenyl diisocyanate (2,4′-MDI), 1-isocyanatomethyl-3-isocyanato-1,5,5-trimethylcyclohexane (isophorone diisocyanate, IPDI), 2-isocyanatopropylcyclohexyl isocyanate, 1-methyl-2,4-diisocyanatocyclohexane, hydrogenation products of the aforementioned aromatic diisocyanates, 1,6-diisocyanato2,2,4-trimethylhexane, 1,6-diisocyanato-2,4,4-trimethylhexane, 2-butyl-2-ethylpentamethylene diisocyanate and lysine diisocyanate.

5 . The curable composition according to claim 1 , wherein E is an aromatic residue comprising phenolic hydroxyl groups.

6 . The curable composition according to claim 1 , wherein z is an integer of 2 to 6.

7 . The curable composition according to claim 1 , where in P is a polyether, X and Y are O, D is a residue obtained by removing the two isocyanate groups of 2,4-toluene diisocyanate or 2,4′-methylenediphenyl diisocyanate, E is an aromatic residue comprising a phenolic hydroxyl group, and z=2 or 3.

8 . The curable composition according to claim 1 , wherein P is a three-valent residue (z=3) derived from a trimethylolpropane.

9 . The composition according to claim 1 , wherein the N-arylated benzoxazine component comprises one or more of

where m is 1-4, X is selected from a direct bond (when m is 2), alkyl (when m is 1), alkylene (when m is 2-4), carbonyl (when m is 2), oxygen (when m is 2), thiol (when m is 1), sulfur (when m is 2), sulfoxide (when m is 2), and sulfone (when m is 2), R 1 is aryl, and R 4 is selected from hydrogen, halogen, alkyl, alkenyl, or R 4 is a divalent residue creating a naphthoxazine residue out of the benzoxazine structure, or

wherein p is 2, Y is selected from the group consisting of biphenyl (when p is 2), diphenyl methane (when p is 2), diphenyl isopropane (when p is 2), diphenyl sulfide (when p is 2), diphenyl sulfoxide (when p is 2), diphenyl sulfone (when p is 2), and diphenyl ketone (when p is 2), and R 4 is selected from the group consisting of hydrogen, halogen, alkyl and alkenyl.

10 . The composition according to claim 1 , wherein the N-arylated benzoxazine component is present in an amount in the range of about 50 to about 95 percent by weight, based on the total weight of the composition.

11 . The composition according to claim 1 , further containing an epoxy resin component.

12 . A cured reaction product of the composition comprising a layer or bundle of fibers infused with the composition of claim 1 .

13 . A process for producing a cured reaction product, steps of which comprise:

A) providing a layer or bundle of fibers;

B) providing the composition according to claim 1 ;

C) joining the composition and the layer or bundle of fibers to form an assembly,

D) optionally removing excess heat curable composition from the assembly exposing the resulting assembly to elevated temperature and pressure conditions sufficient to infuse the layer or bundle of fibers with the heat curable composition to form the cured reaction product.

14 . An adhesive, sealant or coating composition comprising or consisting of the composition according to claim 1 .

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 19, 2018
From: HENKEL AG & CO. KGAA; HENKEL IP & HOLDING GMBH
To: KANEKA AEROSPACE LLC
Reel/Frame 045272/0236 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 26, 2015
From: HENKEL US IP LLC
To: HENKEL IP & HOLDING GMBH
Reel/Frame 035100/0151 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 7, 2014
From: HENKEL CORPORATION
To: HENKEL US IP LLC
Reel/Frame 034183/0611 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 20, 2014
From: LEHMANN, STANLEY L.
To: HENKEL CORPORATION
Reel/Frame 032256/0598 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 20, 2014
From: KREILING, STEFAN; SCHOENFELD, RAINER; TADEN, ANDREAS; KUX, MICHAEL; KUSTER, HARALD
To: HENKEL AG & CO. KGAA
Reel/Frame 032256/0770 →